Q32 Bio(DE:DB0)
€8.34+-0.03 (+1.21%)
DE:DB0
Q32 Bio financials statements
€8.34
At close:+-0.03 (+1.21%)
Q32 Bio (DB0) Income Statement
2 Followers
Q32 Bio Income Statement
Last quarter (Q3 2026), Q32 Bio's total revenue was $0.00. In Q3, Q32 Bio's net income was $16.55M. See Q32 Bio’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 53.74M | $ 0.00 | $ -6.65M | $ 6.65M | $ 0.00 | |
| $ 53.74M | $ 0.00 | $ -6.65M | $ 6.65M | $ 0.00 | |
| $ 36.84M | $ 66.10M | $ 41.60M | $ 45.88M | $ 36.69M | |
| Depreciation and Amortization | $ 391.00K | $ 487.00K | $ 499.00K | $ 370.00K | $ 9.54M |
| $ 31.31M | $ -44.50M | $ -47.76M | $ -38.85M | $ -27.15M | |
| $ 16.90M | $ -66.10M | $ -48.26M | $ -39.23M | $ -36.69M | |
| $ 12.92M | $ 18.39M | $ -5.17M | $ -3.52M | $ -324.00K | |
| $ 29.82M | $ -47.71M | $ -53.42M | $ -42.75M | $ -37.02M | |
| $ 29.82M | $ -47.73M | $ -53.74M | $ -42.81M | $ -37.56M | |
| Per Share Metrics | |||||
| Basic EPS | $ 2.42 | $ -5.12 | $ -4.51 | $ -3.59 | $ -3.15 |
| Diluted EPS | $ 2.42 | $ -6.58 | $ -4.51 | $ -3.59 | $ -3.15 |
| Weighted Average Shares Outstanding | 12.30M | 9.32M | 11.93M | 11.93M | 11.93M |
| Weighted Average Shares Outstanding (Diluted) | 12.31M | 9.66M | 11.93M | 11.93M | 11.93M |
Currency in USD
